Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
RESEARCH TOOLSreports
Holding TMCI?
Track your performance easily
TMCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.92 - $15.98
Previous CloseN/A
Volume76.56K
Average Volume (3M)302.41K
Market Cap
$574.38M
Enterprise Value$348.25M
Total Cash (Recent Filing)$12.14M
Total Debt (Recent Filing)$19.22M
Price to Earnings (P/E)―
Beta2.17
Next Earnings
Feb 27, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding62,297,077
10 Day Avg. Volume411,208
30 Day Avg. Volume302,407
Standard Deviation0.20
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.83
Price to Cash Flow (P/CF)-12.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue1.72
Enterprise Value/Gross Profit2.29
Enterprise Value/Ebitda-7.23
Forecast
1Y Price Target
$10.00Price Target Upside5.71% Upside
Rating ConsensusHold
Number of Analyst Covering6
Treace Medical Concepts News
PremiumCompany Announcements
Treace Medical Concepts Reports Strong 2024 Revenue Growth
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company announced preliminary Q4 and FY24 revenue results that are higher than both the estimates and consensus, showing strong financial performance.
Growth And Innovation10 new product launches throughout 2H24 and 2025 set for broad rollout, like the addressable bunion procedure expanding Nanoplasty and Percuplasty minimally-invasive osteotomy systems.
Market OpportunityThe foot and ankle orthopedics market is a $5B+ global market growing at a 7%-8% CAGR, yet it is largely ignored by investors and industry participants, presenting a great deal of opportunity for investors.
Bears Say
Competitive ConcernsInvestors over the last dozen or so months have experienced multiple significant drawdowns mainly related to softness in bunion procedures and competitive concerns.
Investor SentimentInvestors have experienced significant drawdowns related to softness in bunion procedures and competitive concerns, leading to a lack of enthusiasm for Treace.
Market CompetitionTMCI will have to win back customers through a competitive osteotomy offering, given the competitive landscape.
---
Ownership Overview
29.51% Insiders
10.58% Mutual Funds
0.03% Other Institutional Investors
46.80% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMCI FAQ
What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $3.92 and its highest was $15.98 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Treace Medical Concepts’s market cap is $574.38M.
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s upcoming earnings report date is Feb 27, 2025 which is in 28 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on Nov 05, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.272 by $0.022.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Undervalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -0.04.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 62,297,077 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.272. Following the earnings report the stock price went up 35.069%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Currently, no hedge funds are holding shares in TMCI
---
Treace Medical Concepts Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.00 (5.71% Upside)
$10.00 (5.71% Upside)
Blogger Sentiment
Bearish
TMCI Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 35.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ―
Last 30 Days ―
Last 30 Days ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.02%
12-Months-Change
Fundamentals
Return on Equity
-50.69%
Trailing 12-Months
Asset Growth
-11.41%
Trailing 12-Months
Company Description
Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly.
---
TMCI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a mix of positive developments and challenges. Highlights included strong revenue growth, successful product launches, and improved reimbursement rates, suggesting strategic progress and financial improvements. However, increased operating expenses, ongoing net losses, and potential market challenges were notable concerns. Overall, the company's growth initiatives and financial improvements slightly outweigh the challenges.Read More>---
TMCI Stock 12 Month Forecast
Average Price Target
$10.00
▲(5.71% Upside)
Technical Analysis
Best Analysts Covering TMCI
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+23.15%
reiterated a buy rating 2 days ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.15% per trade.
---